Skin cancer is among the most prevalent cancers globally, emphasizing the need for early detection and accurate diagnosis to improve outcomes. Traditional diagnostic methods, based on visual examination, are subjective, time-intensive, and require specialized expertise. Current artificial intelligence (AI) approaches for skin cancer detection face challenges such as computational inefficiency, lack of interpretability, and reliance on standalone CNN architectures. To address these limitations, this study proposes a comprehensive pipeline combining transfer learning, feature selection, and machine-learning algorithms to improve detection accuracy. Multiple pretrained CNN models were evaluated, with Xception emerging as the optimal choice for its balance of computational efficiency and performance. An ablation study further validated the effectiveness of freezing task-specific layers within the Xception architecture. Feature dimensionality was optimized using Particle Swarm Optimization, reducing dimensions from 1024 to 508, significantly enhancing computational efficiency. Machine-learning classifiers, including Subspace KNN and Medium Gaussian SVM, further improved classification accuracy. Evaluated on the ISIC 2018 and HAM10000 datasets, the proposed pipeline achieved impressive accuracies of 98.5% and 86.1%, respectively. Moreover, Explainable-AI (XAI) techniques, such as Grad-CAM, LIME, and Occlusion Sensitivity, enhanced interpretability. This approach provides a robust, efficient, and interpretable solution for automated skin cancer diagnosis in clinical applications.

Background: Parkinson’s disease (PD) is the second most common neurodegenerative disorder after Alzheimer’s disease, affecting countless individuals worldwide. PD is characterized by the onset of a marked motor symptomatology in association with several non-motor manifestations. The clinical phase of the disease is usually preceded by a long prodromal phase, devoid of overt motor symptomatology but often showing some conditions such as sleep disturbance, constipation, anosmia, and phonatory changes. To date, speech analysis appears to be a promising digital biomarker to anticipate even 10 years before the onset of clinical PD, as well serving as a useful prognostic tool for patient follow-up. That is why, the voice can be nominated as the non-invasive method to detect PD from healthy subjects (HS). Methods: Our study was based on cross-sectional study to analysis voice impairment. A dataset comprising 81 voice samples (41 from healthy individuals and 40 from PD patients) was utilized to train and evaluate common machine learning (ML) models using various types of features, including long-term (jitter, shimmer, and cepstral peak prominence (CPP)), short-term features (Mel-frequency cepstral coefficient (MFCC)), and non-standard measurements (pitch period entropy (PPE) and recurrence period density entropy (RPDE)). The study adopted multiple machine learning (ML) algorithms, including random forest (RF), K-nearest neighbors (KNN), decision tree (DT), naïve Bayes (NB), support vector machines (SVM), and logistic regression (LR). Cross-validation technique was applied to ensure the reliability of performance metrics on train and test subsets. These metrics (accuracy, recall, and precision), help determine the most effective models for distinguishing PD from healthy subjects. Result: Among all the algorithms used in this research, random forest (RF) was the best-performing model, achieving an accuracy of 82.72% with a ROC-AUC score of 89.65%. Although other models, such as support vector machine (SVM), could be considered with an accuracy of 75.29% and a ROC-AUC score of 82.63%, RF was by far the best one when evaluated across all metrics. The K-nearest neighbor (KNN) and decision tree (DT) performed the worst. Notably, by combining a comprehensive set of long-term, short-term, and non-standard acoustic features, unlike previous studies that typically focused on only a subset, our study achieved higher predictive performance, offering a more robust model for early PD detection. Conclusions: This study highlights the potential of combining advanced acoustic analysis with ML algorithms to develop non-invasive and reliable tools for early PD detection, offering substantial benefits for the healthcare sector.

Background: Parkinson’s disease (PD) is the second most common neurodegenerative disorder after Alzheimer’s disease affecting countless individuals worldwide. PD is characterized by the onset of a marked motor symptomatology in association with several nonmotor manifestations. The clinical phase of the disease is usually preceded by a long prodromal phase, devoid of overt motor symptomatology but often showing some conditions such as sleep disturbance, constipation, anosmia, and phonatory changes. To date, speech analysis appears to be a promising digital biomarker to anticipate even 10 years the onset of clinical PD, as well serving as a useful prognostic tool for patient follow-up. That is why, the voice can be nominated as the non-invasive method to detect PD from healthy subjects (HS).

Introduction: Voice-based digital biomarkers have emerged as a promising approach for distinguishing individuals with neurodegenerative disorders, particularly Parkinson’s disease (PD), from healthy subjects (HS). With the increasing availability of smartphone and web-based recording tools, voice data can be collected efficiently in both clinical and remote settings. However, further validation is required before such approaches can be translated into routine clinical practice. Methods: This study used a cross-sectional analysis at the recording level, treating repeated recordings from the same participant as separate observations collected at Vito Fazzi Hospital in Lecce, Italy. Speech recordings from individuals with Parkinson’s disease (PD) and healthy controls were collected using the dedicated Talia smartphone and web application. Sustained vowel phonation (/a/) was analyzed as the primary speech task. Following data acquisition, feature extraction was performed as a crucial step in the speech analysis pipeline, as the quality and relevance of the extracted features directly influence the ability of machine learning models to discriminate between Parkinson’s disease (PD) patients and healthy controls. To capture various aspects of speech impairment associated with PD, a comprehensive set of acoustic features was extracted, including long-term features (pitch, jitter, and shimmer), nonlinear descriptors such as Recurrence Period Density Entropy (RPDE), and short-term feature based on Mel-Frequency Cepstral Coefficients (MFCCs). These features were subsequently used to develop and evaluate machine learning models for the classification of Parkinson’s disease and healthy subjects. Feature selection was performed using SHAP to identify the most informative vocal biomarkers. Model performance was assessed using five independent random train–test splits (70% training and 30% testing), supported by an internal five-fold cross-validation procedure within the training data. Multiple machine learning models were developed and evaluated, including Random Forest, Logistic Regression, Support Vector Machine, Naive Bayes, K-Nearest Neighbors, Decision Tree, Artificial Neural Network, and Gradient Boosting. Results: The evaluated models demonstrated strong recording-level classification performance. Artificial Neural Networks (ANN) and K-Nearest Neighbors (KNN) achieved the highest accuracy scores (0.9545 and 0.9494, respectively), along with superior recall (up to 0.9500), precision (up to 0.9551), and F1-score (up to 0.9525). Both models also exhibited excellent discriminative ability, with ROC-AUC values reaching 0.9882 (ANN) and 0.9893 (KNN). In contrast, Naive Bayes and Decision Tree showed comparatively lower performance across all metrics. Log-loss analysis further confirmed the robustness of ANN and KNN, which achieved the lowest values (0.2552 and 0.2510, respectively), indicating well-calibrated predictions. Overall, the findings highlight the consistency and generalizability of ANN and KNN across cross-validation splits. Conclusions: This study demonstrates that machine learning models, particularly ANN and KNN, can effectively differentiate Parkinson’s disease from healthy conditions using voice recordings. The integration of explainable AI for feature selection enhances model transparency and clinical relevance. However, the reported performance estimates were obtained from a recording-level analysis and should be interpreted as preliminary findings. Further studies involving larger cohorts and participant-level validation strategies are required to determine the generalizability and clinical applicability of these approaches.

Speech Emotion Recognition (SER) is an umbrella term that encompasses all Machine Learning & Deep Learning (ML/DL) algorithms used for the very specific task of extracting emotional state from human speech. In literature, various techniques have been utilized to extract emotions from signals, including well-established speech analysis and classification techniques. Using the scoping review method, the paper maps techniques for speech-based emotion recognition. In doing so, it presents elements defining the use of algorithms to assess emotions, for example, databases used for emotion recognition, notions and types of emotions considered, and empirical investigations made toward SER and related limitations. The contribution places particular emphasis on the existing perspectives and practices in order to offer a series of recommendations for future developments.